Ensign Group Inc (ENSG) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ensign Group Inc  (NASDAQ: ENSG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Ensign Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ensign Group Inc's ROI in the second quarter of 2026?
Ensign Group Inc achieved a return on average invested assets (ROI) of 8.09 % in its second quarter of 2026, this is above ENSG's average return on investment of 6.26%.
Ensign Group Incs investments during the 12 months ending in the second quarter of 2026 are valued at $4 billion

ROI has improved compared to 8.05% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 75 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 788 to 1374.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 15.95 % 15 % 13.77 % 11.86 % 11.58 %
Y / Y Net Income Change TTM 17.3 % 17.37 % 50.01 % 119.36 % 353.96 %
Investment (TTM) in Millions 4,868 4,767 4,710 4,405 4,178
Return On Investment (TTM) 8.09 % 8.05 % 7.94 % 7.86 % 7.99 %
ENSG's Overall Ranking # 1374 # 788 # 371 # 1183 # 953
Seq. Investment Change TTM 3.82 % 4.09 % 3.83 % 3.34 % 2.97 %
Seq. Net Income Change TTM 4.23 % 5.64 % 4.81 % 1.65 % 4.29 %
Net Income (TTM) in Millions 379 364 344 328 323

ENSG Company Profile >> Back to ENSG Roi Comparisons >> See Annual ENSG Return On Investment



Return On Investment ENSG's Ranking
Within: No.
Industry # 13
Sector # 76
Overall # 1374

Return On Investment Statistics
High Average Low
12.24 %
6.26 %
-0.33 %
(Jun 30 2015)  







Financial Statements
Ensign Group Inc's II. Quarter Investments $ 4,868 Millions ENSG's Balance sheet
Ensign Group Inc's II. Quarter Income $ 100 Millions Quarterly ENSG's Income Statement
ENSG's Income by Division See ENSG's Income by Division


ENSG Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 4,572 3,929 3,448 2,871 2,329
Y / Y Investment Growth 16.35 % 13.95 % 20.09 % 23.32 % 17.4 %
Net Income in Millions 344 298 210 225 198
Y / Y Net Income Growth 15.35 % 42.22 % -6.59 % 13.62 % 15.38 %
Annual Return On Investment 7.53 % 7.6 % 6.09 % 7.82 % 8.49 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 7.53 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ENSG's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ENSG's Competitors
Subscribers only: Roi for Ensign Group Inc's Suppliers
Subscribers only: Return On Investment for ENSG's Customers

Other Ratios
ENSG's Roa ENSG's Inventory Turnover Ratio ENSG's Growth Rates ENSG's Dividend Statistics
ENSG's Profitability Ratios ENSG's Asset Turnover Ratio ENSG's Dividend Growth
ENSG's Roe ENSG's Valuation Ratios ENSG's Financial Strength Ratios ENSG's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %

Date modified: 2026-09-26T07:13:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.